Vol 25, No 2 (2018)
Original articles — Clinical cardiology
Published online: 2017-05-11

open access

Page views 4002
Article views/downloads 2696
Get Citation

Connect on Social Media

Connect on Social Media

Effect of fluid resuscitation with balanced solutions on platelets: In vitro simulation of 20% volume substitution

Łukasz J. Krzych, Piotr F. Czempik
Pubmed: 28497841
Cardiol J 2018;25(2):254-259.

Abstract

 Background: Fluid resuscitation in massive bleeding may cause coagulation disorders by dilution of platelets and clotting factors or by the impact on their function. The aim of this study was to investigate the effects of balanced crystalloid and colloid solutions on platelets in vitro using complex assessment of coagulation.

Methods: The study group was comprised of 32 American Society of Anesthesiologists physical status class I male volunteers, aged 21–35 (29 ± 4) years, weighting 59–103 (81.2 ± 9.8) kg. Whole blood samples were diluted at a 4:1 ratio with the following fluids: balanced crystalloid (Plasmalyte®), 6% hydroxyethyl starch 130/0.4 (Volulyte®) and succinylated gelatin (Geloplasma®). Coagulation was as­sessed using standard morphology, rotational thromboelastometry and aggregometry.

Results: Dilution with all fluids caused statistically significant drop in the number of platelets (p < 0.01) but the effect did not differ between solutions (p > 0.05 for all). Other platelet parameters, such as platelet distribution width, mean platelet volume and platelet-large cell ratio were not affected by the solutions. Hemodilution had no effect on platelet function (p = 0.1). Decreased platelet component of clot strength was found for all three fluids (p < 0.05), although the effect for colloids was more pronounced.

Conclusions: The effect of balanced crystalloids and colloids on platelet aggregation was insignificant, even after 20% volume substitution with the resuscitation fluids. (

Article available in PDF format

View PDF Download PDF file

References

  1. Starczewska MH, Giercuszkiewicz D, Niewiński G, et al. Perioperative bleeding in patients undergoing liver transplantation. Anaesthesiol Intensive Ther. 2016; 48(1): 34–40.
  2. Tieu BH, Holcomb JB, Schreiber MA. Coagulopathy: its pathophysiology and treatment in the injured patient. World J Surg. 2007; 31(5): 1055–1064.
  3. Kozek-Langenecker SA, Ahmed AB, Afshari A, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2013; 30(6): 270–382.
  4. Rossaint R, Bouillon B, Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care. 2016; 20: 100.
  5. Williams P, Yang K, Kershaw G, et al. The effects of haemodilution with hydroxyethyl starch 130/0.4 solution on coagulation as assessed by thromboelastography and platelet receptor function studies in vitro. Anaesth Intensive Care. 2015; 43(6): 734–739.
  6. Lima-Oliveira G, Lippi G, Salvagno GL, et al. Venous stasis and whole blood platelet aggregometry: a question of data reliability and patient safety. Blood Coagul Fibrinolysis. 2015; 26(6): 665–668.
  7. Karlsson M, Roman-Emanuel C, Thimour-Bergström L, et al. Sampling conditions influence multiple electrode platelet aggregometry in cardiac surgery patients. Scand Cardiovasc J. 2013; 47(2): 98–103.
  8. Thalén S, Forsling I, Eintrei J, et al. Pneumatic tube transport affects platelet function measured by multiplate electrode aggregometry. Thromb Res. 2013; 132(1): 77–80.
  9. Bolliger D, Seeberger MD, Tanaka KA, et al. Pre-analytical effects of pneumatic tube transport on impedance platelet aggregometry. Platelets. 2009; 20(7): 458–465.
  10. Skhirtladze K, Base EM, Lassnigg A, et al. Comparison of the effects of albumin 5%, hydroxyethyl starch 130/0.4 6%, and Ringer's lactate on blood loss and coagulation after cardiac surgery. Br J Anaesth. 2014; 112(2): 255–264.
  11. Stissing T, Dridi NP, Ostrowski SR, et al. The influence of low platelet count on whole blood aggregometry assessed by Multiplate. Clin Appl Thromb Hemost. 2011; 17(6): E211–E217.
  12. Hanke AA, Roberg K, Monaca E, et al. Impact of platelet count on results obtained from multiple electrode platelet aggregometry (Multiplate). Eur J Med Res. 2010; 15(5): 214–219.
  13. Treib J, Haass A, Pindur G, et al. [Decrease of thrombocyte volume after several days infusion of highly substituted medium molecular weight hydroxyethyl starch (HAES 200/0.62)]. Wien Klin Wochenschr. 1996; 108(1): 20–23.
  14. Liu FC, Liao CH, Chang YW, et al. Hydroxyethyl starch interferes with human blood ex vivo coagulation, platelet function and sedimentation. Acta Anaesthesiol Taiwan. 2009; 47(2): 71–78.
  15. Schaden E, Wetzel L, Kozek-Langenecker S, et al. Effect of the carrier solution for hydroxyethyl starch on platelet aggregation and clot formation. Br J Anaesth. 2012; 109(4): 572–577.
  16. Li N, Statkevicius S, Asgeirsson B, et al. Effects of different colloid infusions on ROTEM and Multiplate during elective brain tumour neurosurgery. Perioper Med (Lond). 2015; 4: 9.
  17. Evans PA, Glenn JR, Heptinstall S, et al. Effects of gelatin-based resuscitation fluids on platelet aggregation. Br J Anaesth. 1998; 81(2): 198–202.
  18. Heptinstall S. The use of a chelating ion-exchange resin to evaluate the effects of the extracellular calcium concentration on adenosine diphosphate induced aggregation of human blood platelets. Thromb Haemost. 1976; 36(1): 208–220.
  19. de Jonge E, Levi M, Berends F, et al. Impaired haemostasis by intravenous administration of a gelatin-based plasma expander in human subjects. Thromb Haemost. 1998; 79(2): 286–290.
  20. Levi M, Jonge Ede. Clinical relevance of the effects of plasma expanders on coagulation. Semin Thromb Hemost. 2007; 33(8): 810–815.
  21. Harr JN, Moore EE, Chin TL, et al. Platelets are dominant contributors to hypercoagulability after injury. J Trauma Acute Care Surg. 2013; 74(3): 756–62; discussion 762.
  22. Nilsson CU, Strandberg K, Engström M, et al. Coagulation during elective neurosurgery with hydroxyethyl starch fluid therapy: an observational study with thromboelastometry, fibrinogen and factor XIII. Perioper Med (Lond). 2016; 5: 20.
  23. Krzych ŁJ, Czempik PF. Hooves better than potatoes: in vitro effects of balanced crystalloid and colloids on functional parameters of coagulation and fibrinolysis. Pol Arch Intern Med. 2017; 127(3): 209–211.
  24. Solomon C, Ranucci M, Hochleitner G, et al. Assessing the Methodology for Calculating Platelet Contribution to Clot Strength (Platelet Component) in Thromboelastometry and Thrombelastography. Anesth Analg. 2015; 121(4): 868–878.
  25. Nielsen VG, Geary BT, Baird MS. Evaluation of the contribution of platelets to clot strength by thromboelastography in rabbits: the role of tissue factor and cytochalasin D. Anesth Analg. 2000; 91(1): 35–39.
  26. Mazur P, Plicner D, Zdziarska J, et al. Decreased von Willebrand factor ristocetin cofactor activity and increased ADAMTS13 antigen increase postoperative drainage after coronary artery bypass grafting. Eur J Cardiothorac Surg. 2014; 45(2): e26–e32.
  27. Casutt M, Kristoffy A, Schuepfer G, et al. Effects on coagulation of balanced (130/0.42) and non-balanced (130/0.4) hydroxyethyl starch or gelatin compared with balanced Ringer's solution: an in vitro study using two different viscoelastic coagulation tests ROTEMTM and SONOCLOTTM. Br J Anaesth. 2010; 105(3): 273–281.